Changmeng Cai, Ph.D.

Affiliations: 
2007 The University of Toledo 
Area:
Molecular Biology, Oncology
Google:
"Changmeng Cai"

Parents

Sign in to add mentor
Lirim Shemshedini grad student 2007 The University of Toledo
 (sGCalpha1, ETV1, and MRP4 are novel androgen receptor-regulated genes that mediate the multiple functions of this receptor in prostate cancer.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cai C, Han D, Chen S, et al. (2019) ZBTB7A mediates the transcriptional repression activity of the androgen receptor in prostate cancer. Cancer Research
Wang Z, Gao S, Han D, et al. (2019) LSD1 Activates PI3K/AKT Signaling Through Regulating p85 Expression in Prostate Cancer Cells. Frontiers in Oncology. 9: 721
Gao S, Chen S, Han D, et al. (2019) Forkhead domain mutations in FOXA1 drive prostate cancer progression. Cell Research
Zhou F, Gao S, Han D, et al. (2019) TMPRSS2-ERG activates NO-cGMP signaling in prostate cancer cells. Oncogene
Chen S, Cai C, Sowalsky AG, et al. (2018) BMX-mediated regulation of multiple tyrosine kinases contributes to castration resistance in prostate cancer. Cancer Research
Liang Y, Ahmed M, Guo H, et al. (2017) LSD1-Mediated Epigenetic Reprogramming Drives CENPE Expression and Prostate Cancer Progression. Cancer Research
Nyquist MD, Corella A, Burns J, et al. (2017) Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155. Molecular Cancer Research : McR. 15: 521-531
Nyquist MD, Corella A, Burns J, et al. (2017) Exploiting AR Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155. Molecular Cancer Research : McR
Liu X, Gao Y, Ye H, et al. (2017) Positive feedback loop mediated by protein phosphatase 1α mobilization of P-TEFb and basal CDK1 drives androgen receptor in prostate cancer. Nucleic Acids Research
Han D, Gao S, Valencia K, et al. (2016) A novel nonsense mutation in androgen receptor confers resistance to CYP17 inhibitor treatment in prostate cancer. Oncotarget
See more...